• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Tesla, Spirit Airlines, New York Community Bancorp And Other Big Stocks Moving Lower On Monday

    3/4/24 10:40:18 AM ET
    $ACMR
    $ADSE
    $BYND
    $CTKB
    Industrial Machinery/Components
    Technology
    Industrial Specialties
    Consumer Discretionary
    Get the next $ACMR alert in real time by email

    U.S. stocks were lower, with the Dow Jones index falling around 80 points on Monday.

    Shares of Tesla, Inc. (NASDAQ:TSLA) fell during Monday’s session after the company reportedly saw a decline in February China sales.

    Tesla sold 60,365 electric vehicles made in China in February, according to preliminary data released by the China Passenger Car Association, as reported by CnEVPost. The breakdown between exports and domestic sales will be available when the detailed report is released in a week.

    Tesla shares fell 5.4% to $191.79 on Monday.

    Here are some other big stocks recording losses in today’s session.

    • MMTec, Inc. (NASDAQ:MTC) shares fell 21.8% to $2.00.
    • Avidity Biosciences, Inc. (NASDAQ:RNA) declined 16.6% to $16.78. Avidity Biosciences announced new long-term AOC 1001 data from the Marina-OLE trial showing reversal of disease progression in Myotonic Dystrophy Type 1 patients across multiple endpoints.
    • Playtika Holding Corp. (NASDAQ:PLTK) tumbled 14.8% to $6.44
    • New York Community Bancorp, Inc. (NASDAQ:NYCB) declined 13.6% to $3.0650 after the company announced that it identified material weaknesses in its internal controls related to internal loan review, that resulted from ineffective oversight, risk assessment and monitoring activities.
    • Spirit Airlines, Inc. (NYSE:SAVE) dipped 12.1% to $5.68 after the company announced the termination of its merger agreement with JetBlue.
    • Lyell Immunopharma, Inc. (NASDAQ:LYEL) fell 12.1% to $2.70.
    • Sabre Corporation (NASDAQ:SABR) declined 11.6% to $2.3050. Sabre announced exchange of $150 million of existing 4.000% exchangeable senior notes due 2025 for exchangeable senior notes due 2026.
    • Li Auto Inc. (NASDAQ:LI) tumbled 11.6% to $38.49. B of A Securities analyst Ming Hsun Lee maintained Li Auto with a Buy and raised the price target from $57 to $60.
    • Revance Therapeutics, Inc. (NASDAQ:RVNC) dipped 11.2% to $6.20. Revance announced pricing of $100 million public offering of 16 million shares of common stock at a price of $6.25 per share.
    • Beyond Meat, Inc. (NASDAQ:BYND) shares fell 11.3% to $8.67 after the company announced that it was unable to file its annual report due to technical difficulties in assembling the submission for filing. Also, the company said it anticipates it will seek to raise additional capital in 2024.
    • Cytek Biosciences, Inc. (NASDAQ:CTKB) fell 11.1% to $8.14. Cytek Biosciences filed for non-timely 10-K with the U.S. SEC.
    • Sana Biotechnology, Inc. (NASDAQ:SANA) fell 10.8% to $10.04. Sana Biotechnology recently reported a year-over-year increase in quarterly financial results.
    • ADS-TEC Energy PLC (NASDAQ:ADSE) fell 10.5% to $9.71.
    • ACM Research, Inc. (NASDAQ:ACMR) declined 10.6% to $30.32.
    • EyePoint Pharmaceuticals, Inc. (NASDAQ:EYPT) fell 9.5% to $25.33. EyePoint Pharmaceuticals announced appointment of Ramiro Ribeiro, M.D., Ph.D. as Chief Medical Officer.
    • Omeros Corporation (NASDAQ:OMER) fell 9.3% to $4.3350.
    • iRhythm Technologies, Inc. (NASDAQ:IRTC) tumbled 9% to $109.64. iRhythm announced a proposed offering of $450 million of convertible senior notes.
    • Hertz Global Holdings, Inc. (NYSE:HTZ) dipped 7.2% to $7.26.
    • NIO Inc. (NYSE:NIO) declined 6.9% to $5.38.
    • Rivian Automotive, Inc. (NASDAQ:RIVN) fell 6.8% to $10.58.
    • Victoria's Secret & Co. (NYSE:VSCO) fell 5.8% to $26.77.
    • Unity Software Inc. (NYSE:U) fell 5.3% to $27.36.

     

    Now Read This: Bitcoin Surpasses $65,000; Pepe Emerges As Top Gainer

    Get the next $ACMR alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $ACMR
    $ADSE
    $BYND
    $CTKB

    CompanyDatePrice TargetRatingAnalyst
    Tesla Inc.
    $TSLA
    4/14/2026$352.00Sell → Neutral
    UBS
    Tesla Inc.
    $TSLA
    4/13/2026$500.00 → $480.00Outperform
    RBC Capital Mkts
    Lyell Immunopharma Inc.
    $LYEL
    4/10/2026$44.00Buy
    Needham
    Rivian Automotive Inc.
    $RIVN
    4/1/2026$14.00Underperform → Neutral
    DA Davidson
    Li Auto Inc.
    $LI
    3/17/2026$19.00Buy → Neutral
    Goldman
    NIO Inc.
    $NIO
    3/13/2026$6.80Hold → Buy
    HSBC Securities
    Atrium Therapeutics Inc.
    $RNA
    3/11/2026$25.00Overweight
    Wells Fargo
    NIO Inc.
    $NIO
    3/11/2026$6.60Neutral → Buy
    Nomura
    More analyst ratings

    $ACMR
    $ADSE
    $BYND
    $CTKB
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    SEC Form 4 filed by Bishop Hans Edgar

    4 - Sana Biotechnology, Inc. (0001770121) (Issuer)

    4/8/26 4:16:24 PM ET
    $SANA
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    Amendment: SEC Form 4 filed by Sheehan Anne

    4/A - Victoria's Secret & Co. (0001856437) (Issuer)

    4/6/26 5:14:48 PM ET
    $VSCO
    Clothing/Shoe/Accessory Stores
    Consumer Discretionary

    SEC Form 3 filed by new insider Rodda Julianne

    3 - iRhythm Holdings, Inc. (0001388658) (Issuer)

    4/6/26 4:53:58 PM ET
    $IRTC
    Medical/Dental Instruments
    Health Care

    $ACMR
    $ADSE
    $BYND
    $CTKB
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Tesla upgraded by UBS with a new price target

    UBS upgraded Tesla from Sell to Neutral and set a new price target of $352.00

    4/14/26 8:13:10 AM ET
    $TSLA
    Auto Manufacturing
    Industrials

    RBC Capital Mkts reiterated coverage on Tesla with a new price target

    RBC Capital Mkts reiterated coverage of Tesla with a rating of Outperform and set a new price target of $480.00 from $500.00 previously

    4/13/26 9:29:55 AM ET
    $TSLA
    Auto Manufacturing
    Industrials

    Needham initiated coverage on Lyell Immunopharma with a new price target

    Needham initiated coverage of Lyell Immunopharma with a rating of Buy and set a new price target of $44.00

    4/10/26 8:32:14 AM ET
    $LYEL
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $ACMR
    $ADSE
    $BYND
    $CTKB
    SEC Filings

    View All

    SEC Form DEFA14A filed by Sabre Corporation

    DEFA14A - Sabre Corp (0001597033) (Filer)

    4/14/26 9:16:50 AM ET
    $SABR
    Computer Software: Programming Data Processing
    Technology

    SEC Form 424B5 filed by Sana Biotechnology Inc.

    424B5 - Sana Biotechnology, Inc. (0001770121) (Filer)

    4/13/26 5:04:14 PM ET
    $SANA
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    Sana Biotechnology Inc. filed SEC Form 8-K: Other Events, Financial Statements and Exhibits

    8-K - Sana Biotechnology, Inc. (0001770121) (Filer)

    4/13/26 4:10:07 PM ET
    $SANA
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    $ACMR
    $ADSE
    $BYND
    $CTKB
    FDA approvals

    Live FDA approvals issued by the Food and Drug Administration and FDA breaking news

    View All

    FDA Approval for DAXXIFY issued to REVANCE THERAPEUTICS, INC.

    Submission status for REVANCE THERAPEUTICS, INC.'s drug DAXXIFY (SUPPL-2) with active ingredient DAXIBOTULINUMTOXINA-LANM has changed to 'Approval' on 08/11/2023. Application Category: BLA, Application Number: 761127, Application Classification:

    8/14/23 4:38:56 AM ET
    $RVNC
    Biotechnology: Pharmaceutical Preparations
    Health Care

    FDA Approval for DAXXIFY issued to REVANCE THERAPEUTICS, INC.

    Submission status for REVANCE THERAPEUTICS, INC.'s drug DAXXIFY (ORIG-1) with active ingredient daxibotulinumtoixnA-lanm has changed to 'Approval' on 09/07/2022. Application Category: BLA, Application Number: 761127, Application Classification:

    9/8/22 1:11:06 PM ET
    $RVNC
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $ACMR
    $ADSE
    $BYND
    $CTKB
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    $ACMR
    $ADSE
    $BYND
    $CTKB
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Rivian and Redwood Materials Announce Energy Storage Partnership for Manufacturing

    Largest repurposed battery energy storage system for a U.S. automotive manufacturer to cut energy costs, support grid reliability. American automotive and technology company Rivian (NASDAQ:RIVN) and critical materials and energy technology company Redwood Materials today announced a partnership to deploy pioneering battery energy storage at Rivian's Normal, Illinois manufacturing facility. Using more than 100 second-life Rivian battery packs, Redwood and Rivian's solution will initially provide 10 megawatt-hours (MWh) of dispatchable energy to reduce cost and grid load during peak demand periods—saving on cost and supporting grid security and reliability. Rivian will provide EV battery

    4/14/26 12:00:00 PM ET
    $RIVN
    Auto Manufacturing
    Industrials

    Sana Biotechnology and Mayo Clinic Announce Strategic Collaboration Focused on Improving Care in Type 1 Diabetes and Accelerating Development of SC451

    Sana and Mayo Clinic to collaborate across multiple areas with goal of accelerating development of and access to potentially curative therapies for patients with type 1 diabetes Initial efforts will include processes and protocols to improve handling of and clinical care involving SC451, a cell replacement therapy being developed for patients with type 1 diabetes, with a system that can be utilized at Mayo Clinic facilities and other sites around the world Motivated by patient-centric values, collaboration includes Mayo equity investment in Sana SEATTLE and ROCHESTER, Minn., April 13, 2026 (GLOBE NEWSWIRE) -- Sana Biotechnology, Inc. (NASDAQ:SANA), a company focused on changing the pos

    4/13/26 4:05:00 PM ET
    $SANA
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    Beyond Meat® Debuts Latest Beyond Breakfast Sausage® Lineup at Retailers Nationwide Including Kroger, Sprouts Farmers Market and Whole Foods Market

    New Beyond Breakfast Sausage Links and Patties, now made with heart-healthy avocado oil,1 deliver craveable taste, clean ingredients and strong nutrition EL SEGUNDO, Calif., April 13, 2026 (GLOBE NEWSWIRE) -- Beyond Meat, Inc. (NASDAQ:BYND), otherwise known as Beyond The Plant Protein Company™, today announced the nationwide rollout of its latest Beyond Breakfast Sausage lineup at major retailers including Kroger and Sprouts Farmers Market, with Whole Foods Market coming soon. As protein continues to dominate consumer nutrition priorities—with 70% of Americans actively trying to increase intake and nearly half prioritizing protein at breakfast2—the brand is leaning into the morning occa

    4/13/26 6:00:00 AM ET
    $BYND
    Packaged Foods
    Consumer Staples

    President and CEO Duker Jay S. bought $19,724 worth of shares (1,500 units at $13.15) (SEC Form 4)

    4 - EyePoint, Inc. (0001314102) (Issuer)

    3/16/26 4:12:55 PM ET
    $EYPT
    Biotechnology: Laboratory Analytical Instruments
    Industrials

    Large owner Arch Venture Partners Ix, Llc bought $12,499,985 worth of shares (488,090 units at $25.61) (SEC Form 4)

    4 - Lyell Immunopharma, Inc. (0001806952) (Issuer)

    3/9/26 4:36:20 PM ET
    $LYEL
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Large owner Arch Venture Fund Xiii, L.P. bought $12,499,985 worth of shares (488,090 units at $25.61) (SEC Form 4)

    4 - Lyell Immunopharma, Inc. (0001806952) (Issuer)

    3/9/26 4:34:54 PM ET
    $LYEL
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $ACMR
    $ADSE
    $BYND
    $CTKB
    Financials

    Live finance-specific insights

    View All

    Scaling Lithium Operations to Meet Surging Global Demand

    NEW YORK, April 09, 2026 (GLOBE NEWSWIRE) -- Market News Updates News Commentary - Lithium mining is basically riding the same wave as electric vehicles and battery storage, and that wave is getting bigger every year. Demand has been climbing fast because lithium is a core ingredient in rechargeable batteries used in EVs, smartphones, and renewable energy systems. On the supply side, new mines take years to get up and running, so there's often a lag that keeps prices elevated. For investors, that imbalance—strong demand and slower supply growth—is a big part of what's making lithium such an attractive space right now as these Active Companies are looking for opportunities: US Critical Meta

    4/9/26 8:45:00 AM ET
    $ALB
    $LAC
    $SLI
    Major Chemicals
    Industrials
    Metal Mining
    Basic Materials

    Hertz Global Holdings, Inc. to Announce First Quarter 2026 Financial Results on May 7, 2026

    Hertz Global Holdings, Inc. (NASDAQ:HTZ) (the "Company") announced today that it plans to report its first quarter 2026 financial results at 8:00 a.m. ET on Thursday, May 7, 2026, followed by an earnings call at 9:00 a.m. ET. A live webcast of the call will be available on the Investor Relations page of the Company's website at https://ir.hertz.com. To access the call by phone, please register through this link: Hertz Q1 2026 earnings teleco registration, and you will be provided with dial-in details. To avoid delays, we encourage participants to dial into the conference call fifteen minutes ahead of the scheduled start time. A web replay will remain available on the website for approxima

    4/6/26 4:30:00 PM ET
    $HTZ
    Rental/Leasing Companies
    Consumer Discretionary

    Tesla First Quarter 2026 Production, Deliveries & Deployments

    In the first quarter, we produced over 408,000 vehicles, delivered over 358,000 vehicles and deployed 8.8 GWh of energy storage products. Thank you to all of our customers, employees, suppliers, shareholders and supporters who helped us achieve these results. Q1 2026   Production Deliveries Subject to operating lease accounting Model 3/Y 394,611 341,893 1% Other Models 13,775 16,130 2% Total 408,386 358,023 1% Tesla will post its financial results for the first quarter of 2026 after market close on Wednesday, April 22, 2026. At that time, Tesla will issue a brief advisory containin

    4/2/26 9:03:00 AM ET
    $TSLA
    Auto Manufacturing
    Industrials

    $ACMR
    $ADSE
    $BYND
    $CTKB
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    SEC Form SC 13G filed by Spirit Airlines Inc.

    SC 13G - Spirit Airlines, Inc. (0001498710) (Subject)

    12/6/24 9:37:58 AM ET
    $SAVE
    Air Freight/Delivery Services
    Consumer Discretionary

    Amendment: SEC Form SC 13D/A filed by Playtika Holding Corp.

    SC 13D/A - Playtika Holding Corp. (0001828016) (Subject)

    11/27/24 7:48:58 PM ET
    $PLTK
    EDP Services
    Technology

    Amendment: SEC Form SC 13G/A filed by Avidity Biosciences Inc.

    SC 13G/A - Avidity Biosciences, Inc. (0001599901) (Subject)

    11/14/24 5:46:11 PM ET
    $RNA
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $ACMR
    $ADSE
    $BYND
    $CTKB
    Leadership Updates

    Live Leadership Updates

    View All

    iRhythm Holdings Appoints Jason Patten to its Board of Directors

    SAN FRANCISCO, March 12, 2026 (GLOBE NEWSWIRE) -- iRhythm Holdings, Inc. (NASDAQ:IRTC), a leading digital health care company focused on creating trusted solutions that detect, predict, and prevent disease, is pleased to announce the appointment of Jason Patten to its Board of Directors, effective March 12, 2026. Mr. Patten brings decades of strategic leadership in healthcare, reinforcing iRhythm's commitment to innovation, operational excellence, and long-term growth. "We are thrilled to welcome Jason Patten to our Board of Directors at an important moment in iRhythm's evolution," said Abhi Talwalkar, Chairman of the Board of Directors. "As we scale and expand profitability, we are focus

    3/12/26 4:30:00 PM ET
    $IRTC
    Medical/Dental Instruments
    Health Care

    Lyell Immunopharma Reports Q4 and Full Year 2025 Business and Financial Results

    Patient dosing has commenced in first-of-its-kind Phase 3 head-to-head CAR T-cell 2L randomized controlled clinical trial (PiNACLE-H2H) in patients with large B-cell lymphoma, and the 3L+ pivotal trial (PiNACLE) evaluating ronde-cel is ongoingPhase 1 trial is ongoing for LYL273, an enhanced GCC-targeted CAR T-cell candidate for metastatic colorectal cancer; seven new patients treated without dose-limiting toxicity and including dose escalation to Dose Level 3Smital Shah was appointed Chief Financial and Business Officer in March 2026Second $50 million tranche of $100 million equity private placement closed in March 2026 after achievement of clinical milestone for ronde-celCash of approximate

    3/12/26 4:05:00 PM ET
    $LYEL
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Sabre Appoints Niklas Andréen as Chief Commercial Officer, Airline Tech

    New leadership role underscores Sabre's commitment to accelerating airline growth and innovation following its AI-native platform rebuild SOUTHLAKE, Texas, March 10, 2026 /PRNewswire/ -- Sabre (NASDAQ:SABR) today announced the appointment of Niklas Andréen as Chief Commercial Officer, Airline Tech, a role intended to accelerate execution following the company's once-in-a-generation technology rebuild. The appointment reflects growing momentum across Sabre's airline business as customers increasingly adopt modern retailing technology that moves them into the new world of offer-or

    3/10/26 9:00:00 AM ET
    $SABR
    Computer Software: Programming Data Processing
    Technology